Water treatment for contemporary hemodialysis

  • Gianni Cappelli
  • Paola Inguaggiato

Abstract

Chronic hemodialysis treatment became an accepted mode of therapy in the 1960s, and since then the use of inadequately purified water was recognized as being responsible for many documented patients’ injuries and deaths (Table 1) (1–6). It is estimated that many more incidences go unreported since, unless a patient exhibits an acute or subacute reaction, chronic side-effects are usually related to uremia or to the treatment itself. Water represents more than 95% of dialysate, and a dialysis patient is exposed to a mean of 300–400 L of water a week, in contrast to a normal person ingesting 14 L/week. In healthy individuals gastrointestinal mucosa represents an active membrane which regulates transport of a potential toxin into the blood stream and, once entered, contaminants have ready means of excretion.

Keywords

Magnesium Hepatitis Cadmium Manganese Iodine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tipple MA, Shusterman N, Bland LA et al. Illness in hemodialysis patients after exposure to chloramine contaminated dialysate. ASAIO Trans. 1991; 37:588–91.PubMedGoogle Scholar
  2. 2.
    Pyo HJ, Kwon YJ, Wee KS et al. An outbreak of Heinz body positive hemolytic anemia in chronic hemodialysis patients. Korean J Intern Med. 1993;8:93–8.PubMedGoogle Scholar
  3. 3.
    Arnow PM, Bland LA, Garcia-Houchins S, Fridkin S, Fellner SK. An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit. Ann Intern Med. 1994;121:339–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Ward DM. Water disasters: pitfalls and precautions. Contemp Dial Nephrol Mag. 1999; 12. New York: Ashlee.Google Scholar
  5. 5.
    Berend K, van der Voet G, Boer WH. Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Int. 2001;59:746–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Pouria S, de Andrade A, Barbosa J et al. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet. 1998;352:21–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Brunet P, Berland Y. Water quality and complications of haemodialysis. Nephrol Dial Transplant. 2000;15:578–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Bommer J, Ritz E. Water quality: a neglected problem in hemodialysis. Nephron. 1987;46:1–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Cappelli G. Dialysate contribution to bio-incompatibility in hemodialysis. Contemp Dial Nephrol. 1991;12:20–2.Google Scholar
  10. 10.
    Spittle MA. Chronic inflammation and water quality in hemodialysis patients. Nephrol News Issues. 2001;15: 24–6, 28.PubMedGoogle Scholar
  11. 11.
    ANSI/AAMI. Water treatment equipment for hemodialysis applications (RD62:2001). Arlington, VA: AAMI, 2001.Google Scholar
  12. 12.
    European Pharmacopoeia, 3rd edn (Supplement). Haemodialysis solutions, concentrated, water for diluting. Monograph 1997:1167 corrected 2000. Strasbourg: Council of Europe, 2001.Google Scholar
  13. 13.
    Schindler R, Krautzig S, Lufft V et al. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in vitro dialysis with whole blood. Nephrol Dial Transplant. 1996;11:101–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Weber C, Linsberger I, Rafiee-Tehrani M, Falkenhagen D. Permeability and adsorption capacity of dialysis membranes to lipid A. Int J Artif Organs. 1997;20:144–52.PubMedGoogle Scholar
  15. 15.
    Lonnemann G, Schindler R, Lufft V, Mahiout A, Shaldon S, Kock KM. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes. Nephrol Dial Transplant. 1995;10:207–11.PubMedGoogle Scholar
  16. 16.
    European Renal Association. European best practice guidelines, Section IV: Dialysis fluid purity. Nephrol Dial Transplant. 2002;17(Supp1.7):45–62.CrossRefGoogle Scholar
  17. 17.
    Mion CM, Canaud B, Garred LJ, Stec F, Nguyen QV. Sterile and pyrogen-free bicarbonate dialysate: a necessity for haemodialysis today. Adv Nephrol Necker Hosp. 1990;19: 275–314.PubMedGoogle Scholar
  18. 18.
    Tsuchida K, Takemoto Y, Yamagami S et al. Detection of peptidoglycan and endotoxins in dialysate using silkworm larvae plasma and Limulus amoebocyte lysate methods. Nephron. 1997;75:438–43.PubMedCrossRefGoogle Scholar
  19. 19.
    Lonnemann G, Endres S, van der Meer JW, Cannon JG, Dinarello CA. A radio-immunoassay for human interleukin1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin. Limphokine Res. 1988;7:75–84.Google Scholar
  20. 20.
    Morin P. Identification of the bacteriological contamination of a water treatment line used for haemodialysis and its disinfection. J Hosp Infect. 2000;45:218–24.PubMedCrossRefGoogle Scholar
  21. 21.
    Bland LA, Arnow PM, Arduino MJ, Bova J, McAllister SK. Potential hazards of deionization systems used for water purification in hemodialysis. Artif Organs. 1996;20:2–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Cappelli G, Ballestri M, Facchini F, Carletti P, Lusvarghi E. Leaching and corrosion of polyvinyl chloride (PVC) tubes in a dialysis water distribution system. Int J Artif Organs. 1995;18:261–3.PubMedGoogle Scholar
  23. 23.
    Baz M, Durand C, Ragon A et al. Using ultrapure water in haemodialysis delays carpal tunnel syndrome. Int J Artif Organs. 1991;14:681–5.PubMedGoogle Scholar
  24. 24.
    Bunn WW, Haas, BB, Deane ER, Kleopfer RD. Formation of trihalomethanes by chlorination of surface water. Environ Lett. 1975;10:205–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Formica M, Vallero A, Forneris G et al. Organohalogen contamination of a dialysis-water treatment plant. G Ital Nefrol. 2002:19:479–82.PubMedGoogle Scholar
  26. 26.
    Amato RL. Water treatment for hemodialysis, including the latest AAMI standards. Nephrol Nurs J. 2001;28:619–31.PubMedGoogle Scholar
  27. 27.
    Smeets E, Kooman J, Van Der Sande F et al. Prevention of biofilm formation in dialysis water treatment systems. Kidney Int. 2003;63:1574–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Jensen E. Ozone, the alternative for clean dialysis water. Dial Transplant. 1998,27:706–12.Google Scholar
  29. 29.
    Vincent FC, Tibi AR, Darbord JC. A bacterial biofilm in a hemodialysis system. Assessment of disinfection and crossino of endotoxin. ASAIO Trans. 1989;35:310–13.PubMedCrossRefGoogle Scholar
  30. 30.
    Cappelli G, Balestri M, Perrone S, Ciuffreda A, Ingaggiato P, Albertazzi P. Biofilms invade nephrology: effects in hemodialysis. Blood Purif. 2000;18:224–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Marion-Ferey K, Pasmore M, Stoodley P, Wilson S, Husson GP, Costerton JW. Biofilm removal from silicone tubing: an assessment of the efficacy of dialysis machine decontamination procedures using an in vitro model. J Hosp Infect. 2003;53:64–71.PubMedCrossRefGoogle Scholar
  32. 32.
    Arduino MJ. Proper mechanisms for assuring disinfectant concentration for use in hemodialysis. Nephrol News Issues. 1999;13:18, 23, 27.PubMedGoogle Scholar
  33. 33.
    Nystrand R. Dialysis fluid contamination of pathways and life of microbes. EDTNA-ERCA J. 2001 27:135–9.PubMedGoogle Scholar
  34. 34.
    Harding GB, Pass T, Million C, Wright R, DeJarnette J, Klein E. Bacterial contamination of hemodialysis center water and dialysis fluid: are current assays adequate? Artif Organs. 1989;13:155–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Arduino MJ, Bland LA, Aguero SM, Bavero MS. Effects of incubation time and temperature on microbiologic sampling procedures for haemodialysis fluids. J Clin Microbiol. 1991;29:1462–5.PubMedGoogle Scholar
  36. 36.
    Bland LA. Microbiological and endotoxin assays of hemodialysis fluids. Adv Ren Replace Ther. 1995;2:70–9.PubMedGoogle Scholar
  37. 37.
    Food and Drug Administration (FDA). A Manual on Water Treatment for Hemodialysis (FDA 89–4234). Rockville, MD: CDRH, 1989.Google Scholar
  38. 38.
    Canaud B. Quality control in hemodialysis: quality assurance process. Nephrologie. 2000;21:403–11.PubMedGoogle Scholar
  39. 39.
    Klein E, Pass T, Harding GB, Wright R, Million C. Microbial and endotoxin contamination in water and dialysate in central United States. Artif Organs. 1990;14:85–94.PubMedCrossRefGoogle Scholar
  40. 40.
    Kulander L, Nisbeth U, Danielsson BG, Eriksson O. Occurrence of endotoxin in dialysis fluids from 39 dialysis units. J Hosp Infect. 1993;24:29–37.Google Scholar
  41. 41.
    Bambauer R, Schauer M, Jung WK, Daum V, Vienken J. Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J. 1994;40:1012–16.PubMedGoogle Scholar
  42. 42.
    Laurence RA, Lapierre ST. Quality of hemodialysis water: a 7-year multicenter study. Am J Kidney Dis. 1995;25:738–50.PubMedCrossRefGoogle Scholar
  43. 43.
    Arvanitidou M, Spaia S, Katsinas C et al. Microbiological quality of water and dialysate in all hemodialysis centres of Greece. Nephrol Dial Transplant. 1998;13:949–54.PubMedCrossRefGoogle Scholar
  44. 44.
    Vorbeck-Meister I, Sommer R, Vorbeck F, Horl WH. Quality of water used for haemodialysis: bacteriological and chemical parameters. Nephrol Dial Transplant. 1999;14:666–75.PubMedCrossRefGoogle Scholar
  45. 45.
    Arvanitidou M, Spaia S, Askepidis N et al. Endotoxin concentration in treated water of all hemodialysis centres in Greece and inquisition of influencing factors. J Nephrol. 1999;12:32–7.PubMedGoogle Scholar
  46. 46.
    Lonneman G, Krautzig S, Koch KM. Quality of water and dialysate in haemodialysis. Nephrol Dial Transplant. 1996;11:946–9.CrossRefGoogle Scholar
  47. 47.
    Ledebo I, Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs. 1999;23:37–43.PubMedCrossRefGoogle Scholar
  48. 48.
    Canaud B, Bosc JY, Leray H, Stec F. Microbiological purity of dialysate for on-line substitution fluid preparation. Nephrol Dial Transplant. 2000:(Suppl. 2):21–30.Google Scholar
  49. 49.
    Canaud B, Bosc JY, Leray H, Stec F, Argiles A, Leblanc M, Mion C. On-line haemodiafiltration: state of the art. Nephrol Dial Transplant. 1998;13(Suppl. 5):3–11.PubMedCrossRefGoogle Scholar
  50. 50.
    Ward RA. Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis. Semin Dial. 2000;13:378–80.PubMedCrossRefGoogle Scholar
  51. 51.
    Lonnemann G. Should ultra-pure dialysate be mandatory? Nephrol Dial Transplant. 2000;15(Suppl. 1):55–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Lonnemann G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif. 2000;18:214–23.PubMedCrossRefGoogle Scholar
  53. 53.
    Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol DialTransplant. 2001;16:1863–9.CrossRefGoogle Scholar
  54. 54.
    Schiffl H, Wendinger H, Lang SM. Ultrapure dialysis fluid and response to hepatitis B vaccine. Nephron. 2002;91:530–1.PubMedCrossRefGoogle Scholar
  55. 55.
    Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant. 2002; 17(Suppl. 1):53–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Akrum R, Frohlich M, Gerritsen AF, Daha MR, Chang PC. Ultrapure water for dialysate contributes to a lower activation state of peripheral blood mononuclear cells. Kidney Int. 1999;55:1158–71.PubMedCrossRefGoogle Scholar
  57. 57.
    Schiffl H, Lang SM, Fisher R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant. 2002;17:1814–18.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2004

Authors and Affiliations

  • Gianni Cappelli
  • Paola Inguaggiato

There are no affiliations available

Personalised recommendations